Compare Definium Therapeutics Inc. Common Shares (DFTX) vs JPMorgan Nasdaq Equity Premium Income ETF (JEPQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs JPMorgan Nasdaq Equity Premium Income ETF — how do they compare? Definium Therapeutics Inc. Common Shares trades at $35.2 (market cap $4.59B), while JPMorgan Nasdaq Equity Premium Income ETF trades at $61.16 (market cap $44.49B). The key difference: JPMorgan Nasdaq Equity Premium Income ETF is far larger — about 9.7× Definium Therapeutics Inc. Common Shares's market cap, and JPMorgan Nasdaq Equity Premium Income ETF is trading nearer its 52-week high, Definium Therapeutics Inc. Common Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and JPMorgan Nasdaq Equity Premium Income ETF for 65 Days on average.
| DFTX | JEPQ | |
|---|---|---|
Market Cap | $4.59B | $44.49B |
Volume | 2,103,937 | 5,681,789 |
Sector | Health | Income / Options Overlay |
52-Week High | $48.45 | $61.46 |
52-Week Low | $10.68 | $53.77 |
Typical Hold Time | 0 Days | 65 Days |
Enterprise Value | $3.55B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
JEPQ trades at $61.27, showing minimal daily movement with a 0.03% gain. The ETF maintains a bullish technical outlook with strong moving average support, though oscillators signal some near-term caution. Recent dividend distributions of $0.57-$0.70 demonstrate the fund's income generation capability, with financial media highlighting its 11% estimated yield and positioning for AI infrastructure growth.
The covered-call strategy provides downside protection but limits upside potential during strong bull markets. Institutional interest remains positive with recent acquisitions, though investors should note the variable nature of distributions and the trade-off between high current income and long-term capital appreciation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About JPMorgan Nasdaq Equity Premium Income ETF
JEPQ seeks to provide monthly income and exposure to the Nasdaq-100 Index with less volatility. It uses a methodology that combines high-growth tech stocks with an options strategy to capture income.
Read more on JEPQ →
